Protein profile

PA3092

2,4-dienoyl-CoA reductase

Genome: NC_002516.2

Gene: fadH1 PA3092 Structure source: AlphaFold UniProt Q9HZB6
Amino acids 679
Annotations 6
Features 23
PDB binders 3
Druggability 0.529

Overview

Basic information about this protein and its source genome.

Accession
PA3092
Gene
fadH1 PA3092
Status
annotated
Amino acids
679
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
Cytoplasmic

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.529
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

6 GO

Gene Ontology (GO)

6
  • GO:0008670 Catalysis of the reactions: a 4,5-saturated-(2E)-enoyl-CoA + NADP+ = a (2E,4E)-dienoyl-CoA + H+ + NADPH, and a (2E,4Z)-dienoyl-CoA + H+ + NADPH = a 4,5-saturated-(2E)-enoyl-CoA + NADP+.
  • GO:0010181 Binding to flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
  • GO:0051536 Binding to an iron-sulfur cluster, a combination of iron and sulfur atoms.
  • GO:0046872 Binding to a metal ion.
  • GO:0033543 A fatty acid beta-oxidation pathway by which fatty acids having cis-double bonds on even-numbered carbons are degraded. In this pathway, the intermediate 2,4-dienoyl-CoA is converted to trans-2-enoyl-CoA by 2,4-dienoyl-CoA reductase and delta3-delta2-enoyl-CoA isomerase; trans-2-enoyl-CoA returns to the core beta-oxidation pathway for further degradation. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
  • GO:0016491 Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.

Sequence Features

Domain/signature hits from InterPro and related databases.

23 records
Show feature table
Start End DB Term Name
625 641 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
503 521 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
463 481 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
381 400 PRINTS PR00368 FAD-dependent pyridine nucleotide reductase signature
466 657 SUPERFAMILY SSF51905 FAD/NAD(P)-binding domain
466 657 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
4 366 SUPERFAMILY SSF51395 FMN-linked oxidoreductases
475 632 FunFam G3DSA:3.50.50.60:FF:000113 NADPH-dependent 2,4-dienoyl-CoA reductase
475 632 Gene3D G3DSA:3.50.50.60 -
475 632 InterPro IPR036188 FAD/NAD(P)-binding domain superfamily
378 672 Gene3D G3DSA:3.40.50.720 -
379 642 Pfam PF07992 Pyridine nucleotide-disulphide oxidoreductase
379 642 InterPro IPR023753 FAD/NAD(P)-binding domain
6 373 Gene3D G3DSA:3.20.20.70 Aldolase class I
6 373 InterPro IPR013785 Aldolase-type TIM barrel
6 373 FunFam G3DSA:3.20.20.70:FF:000082 NADPH-dependent 2,4-dienoyl-CoA reductase
10 332 Pfam PF00724 NADH:flavin oxidoreductase / NADH oxidase family
10 332 InterPro IPR001155 NADH:flavin oxidoreductase/NADH oxidase, N-terminal
10 362 CDD cd02930 DCR_FMN
626 640 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
380 402 PRINTS PR00411 Pyridine nucleotide disulphide reductase class-I signature
7 679 PANTHER PTHR42917 2,4-DIENOYL-COA REDUCTASE
337 526 SUPERFAMILY SSF51971 Nucleotide-binding domain

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA3092
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
2 0.529

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

3 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
FLC A0A0L8AFM7 189.1 Da LogP -5.25 TPSA 140.6 ✓ Ro5 ✓ Clean C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O
J5H E1YD54 921.7 Da LogP 1.13 TPSA 363.6 3 viol. ✓ Clean CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([…
MDE P42593 994.9 Da LogP 0.91 TPSA 382.6 3 viol. ✓ Clean CCCCC[C@@H](C\C=C\C(=O)SCCNC(=O)CCNC(C(=O)C(C)(…

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.